Quintiles names global head of clinical & data operations

Tuesday, October 11, 2011 10:59 AM

Quintiles has named Steven Skolsky global head of its clinical & data operations (CDO) unit, the core of the company’s clinical development division that monitors the clinical conduct at research sites and collects and manages data from thousands of patients in hundreds of clinical trials conducted around the world.

A 30-year veteran of the biopharmaceutical industry, Skolsky will lead the 5,000-employee CDO unit, which unites clinical data management and clinical operations under one umbrella to accelerate data flow and ensure the quality of Quintiles’ data.

“Steve’s deep knowledge of the industry and proven leadership capabilities will enable Quintiles to increase the value that we deliver to customers in today’s rapidly changing environment we call the New Health,” said Paula Brown Stafford, president of clinical development at Quintiles.

Skolsky previously served as vice chairman of the board and is a current board director for Basilea Pharmaceutica, a Basel, Switzerland-based pharmaceutical company. He also serves as a member of the board of directors for Adherex Technologies.  Most recently, he was principal at Expis Partners, a strategic life science consultancy. He previously served as president and chief executive officer of Sequoia Pharmaceuticals and chief executive officer of Trimeris, and spent more than 20 years at GlaxoSmithKline in a range of senior leadership roles.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs